Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s40360-017-0152-7
Published Online: 2017-06-07
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Tsuboi, Kazuya
Yamamoto, Hiroshi